FDA Guidance for Industry CGMP for Phase 1 Investigational Drugs

Titel:
FDA Guidance for Industry CGMP for Phase 1 Investigational Drugs
Herkunft/Verlag:

Freedom of Information Staff, (HFI 35), Food and Drug Administration, Rm. 12 A - 30, 5600 Fishers Lane, Rockville, MD 20857, USA, http://www.fda.gov/ , http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM070273.pdf

Dokumentenart:
Guidance for Industry DRAFT
Inhalt:
GMP in der Phase 1 von IND

Zurück

GMP Seminare nach Thema